Address: Kalman Imre Ut 1 H-1054 Budapest,Hungary
Tel: +36 1 475 1354
Committed to Improving the Lives of Patients Worldwide
Celgene is a global biopharmaceutical company committed to improving the lives of patients worldwide.
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our mission as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocyte leukemia (CLL), non-Hodgkin’s lymphoma (NHL), myelofibrosis, small cell lung cancer and prostate cancer.
As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
Products and services
ABRAXANE® (for injectable suspension)
ISTODAX® (romidepsin) for injection
VIDAZA® (azacitidine for injection)
LifebankUSA (placental and cord blood banking)
ABRAXANE®, ISTODAX®, REVLIMID®, THALOMID®, VIDAZA® are registered trademarks of Celgene Corporation.